IP Library › Granted Patent US 8,309,073
Granted Patent B2
US 8,309,073 · App. 10/470,151 · Granted Nov 13, 2012

Combination of probiotics

Assignee: Valio Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,309,073
App. No.
10/470,151
Granted
Nov 13, 2012
Kind
B2
Abstract

The invention relates to a probiotic combination comprising different combinations of lactobacilli, propionic acid bacteria and/or bifidobacteria. The probiotics are preferably combined with a suitable prebiotic to form a synbiotic. The combination of the invention can be consumed as such or combined with a suitable foodstuff or pharmaceutical product, and it is therapeutically useful for example for stimulating the immune system and for general health improvement.

Claims (31)

1. A composition of probiotics which consists of Lactobacillus rhamnosus GG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp. shermanii JS (DSM 7067) and a bifidobacterium, wherein the bifidobacterium is Bifidobacterium infantis Bbi99 (DSM 13692) or Bifidobacterium lactis Bb12, and the amount of probiotics in the composition is sufficient to produce a probiotic effect.

2. The composition of claim 1 , wherein the bifidobacterium is Bifidobacterium infantis Bbi99 (DSM 13692).

3. The composition of claim 1 , comprising from about 10 6 colony forming units (cfu) to about 10 10 cfu of each of the probiotics.

4. The composition of claim 1 , wherein the bifidobacterium is Bifidobacterium lactis Bb12.

5. The composition of claim 1 , wherein the amount of the probiotics in the composition is sufficient to reduce formation of carcinogenic or other harmful compounds.

6. A probiotic composition comprising only four probiotic strains Lactobacillus rhamnosus GG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp. shermanii JS (DSM 7067) and a bifidobacterium, wherein the bifidobacterium is Bifidobacterium infantis Bbi99 (DSM 13692) or Bifidobacterium lactis Bb12, in amounts sufficient to produce a probiotic effect; and at least starter microbes used in the dairy industry or a prebiotic.

7. The probiotic composition of claim 6 comprising both starter microbes and a prebiotic.

8. The probiotic composition of claim 6 comprising a prebiotic which is an oligosaccharide.

9. The probiotic composition of claim 8 , wherein the oligosaccharide is a galacto-oligosaccharide.

10. The composition of claim 6 , wherein the amount of the probiotic strains in the probiotic composition is sufficient to reduce formation of carcinogenic or other harmful compounds.

11. A probiotic composition comprising only four probiotic strains Lactobacillus rhamnosus GG (ATCC 53103), Lactobacillus rhamnosus LC705 (DSM 7061), Propionibacterium freudenreichii ssp. shermanii JS (DSM 7067) and a bifidobacterium, wherein the bifidobacterium is Bifidobacterium infantis Bbi99 (DSM 13692) or Bifidobacterium lactis Bb12, in amounts sufficient to produce a probiotic effect; and a prebiotic.

12. The composition of claim 11 , wherein the amount of the probiotic strains in the probiotic composition is sufficient to reduce formation of carcinogenic or other harmful compounds.

13. A method of using the composition of claim 1 in preparing a product selected from the group consisting of foodstuff products, products of beverage or confectionary industry, health-promoting products and natural products.

14. The method of claim 13 further comprising using at least starter microbes or a prebiotic in preparing the product.

15. The method of claim 14 , wherein starter microbes and a prebiotic are used to prepare the product.

16. The method of claim 13 , wherein the product is a dairy product, drink, juice or children's food.

17. The method of claim 13 , wherein the product is in single dose form.

18. The method of claim 17 , wherein the single dose form is a capsule.

19. The method of claim 14 , wherein the prebiotic is an oligosaccharide and is used to prepare the product.

20. The method of claim 19 , wherein the oligosaccharide is a galacto-oligosaccharide.

21. A method of adding the composition of claim 1 to a product selected from the group consisting of foodstuff products, products of beverage or confectionary industry, health-promoting products and natural products.

22. The method of claim 21 further comprising adding at least starter microbes or a prebiotic to the product.

23. The method of claim 22 , wherein starter microbes and a prebiotic are added to the product.

24. The method of claim 21 , wherein the product is a dairy product, drink, juice or children's food.

25. The method of claim 21 , wherein the product is in single dose form.

26. The method of claim 25 , wherein the single dose form is a capsule.

27. The method of claim 22 , wherein the prebiotic is an oligosaccharide and is added to the product.

28. The method of claim 27 , wherein the oligosaccharide is a galacto-oligosaccharide.

29. A method of using the composition of claim 1 which is comprised of providing the composition to a human for consumption.

30. The method of claim 29 , wherein the composition is provided as a dairy product, drink, juice, soup or children's food.

31. The method of claim 29 , wherein the composition is provided as a capsule.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2017
From: VALIO LTD.
To: CHR. HANSEN A/S
Reel/Frame 042272/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2003
From: MAYRA-MAKINEN, ANNIKA; SUOMALAINEN, TARJA; VAARALA, OUTI
To: VALIO LTD.
Reel/Frame 014736/0232 →
Priority Claims (1)
FI 20010157 · Jan 25, 2001 · national
Continuity (1)
Related Publication 20040062758A1 · Apr 1, 2004